Vicky A. Appleman
Impact in
-
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Response and Inflammation
-
- Viral Infections and Vectors
Papers in
- Immunology 10
- interferon and immune responses 7
- Immune cells in cancer 3
- Oncology 8
- Cancer Immunotherapy and Biomarkers 6
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Adnan O. Abu‐Yousif (6 shared papers)Michelle L. Ganno (3 shared papers)Michaela Prado (1 shared paper)Shiran Ferber (1 shared paper)Steven Langston (1 shared paper)David Lok (1 shared paper)Pere Dosta (1 shared paper)Jianing Wang (1 shared paper)
- Journals
- Cancer Research (5 papers)Journal of Clinical Oncology (2 papers)Life Science Alliance (1 paper)Oncogene (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United StatesCosta Rica
In The Last Decade
Vicky A. Appleman
11 papers receiving 184 citations
Vicky A. Appleman's Hit Papers
Peers
Comparison fields: 5 of 34
- Immunology 137
- Infectious Diseases 46
- Oncology 41
- Genetics 15
- Cancer Research 20
Countries citing papers authored by Vicky A. Appleman
This map shows the geographic impact of Vicky A. Appleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky A. Appleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky A. Appleman more than expected).
Fields of papers citing papers by Vicky A. Appleman
This network shows the impact of papers produced by Vicky A. Appleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky A. Appleman. The network helps show where Vicky A. Appleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Vicky A. Appleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles Hit paper breakdown → | 2023 | 103 |
| 2 | 2022 | 17 | |
| 3 | 2021 | 16 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 7 | |
| 7 | 2018 | 5 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 0 |
About Vicky A. Appleman
Vicky A. Appleman is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 12 papers that have together received 186 indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cytokine Signaling Pathways and Interactions (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune cells in cancer (3 papers), Ubiquitin and proteasome pathways (2 papers), Glioma Diagnosis and Treatment (2 papers) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Immunology (137 citations), Infectious Diseases (46 citations), Oncology (41 citations), Genetics (15 citations) and Cancer Research (20 citations). Vicky A. Appleman has collaborated with scholars based in United States and Costa Rica. Frequent co-authors include Adnan O. Abu‐Yousif, Michelle L. Ganno, Michaela Prado, Shiran Ferber, Steven Langston, David Lok, Pere Dosta, Jianing Wang, Walid S. Kamoun and Natalie Artzi. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Life Science Alliance, Oncogene and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.